Ved behandling af rotter med tipranavir ved 0, 8 gange human behandling ved klinisk dosis observeredes føtal toksicitet (nedsat sternebrae ossifikation og kropsvægt).
At tipranavir exposures in rats at 0.8-fold human exposure at the clinical dose, foetal toxicity (decreased sternebrae ossification and body weights) was observed.